HEPATITIS E

 

HEPATITIS E

 

DEFINITION:

An infectious disease of the liver caused by the hepatitis E virus (HEV) resulting in an acute hepatitis lasting several weeks to months.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • rare in children and most common in adults
  • risk factors:
    • epidemic (water-borne epidemics in China, Asia, Africa, Mexico, Central America)
    • very rare in North America

PATHOGENSIS:

1. Etiology

1. Hepatitis E Virus

  • a single-stranded RNA calcivirus 27-30 nm in diameter
  • cloned in 1990
  • routes of infection:
    • usually fecal-oral
    • can be water-borne
    • rarely if ever parenteral

2. Hepatitis E

  • previously called "enterically-transmitted non-A, non-B hepatitis"
  • secondary attack rate in household contacts is <3%

2. Pathogenesis

  • infection -> 2-9 week incubation period -> hepatocellular damage (elevated ALT) -> hepatitis

CLINICAL FEATURES:

1. Prodrome

  • arthritis and rash are not present

2. Hepatitis

  • clinical manifestations and course essentially the same as for
  • Hepatitis A
  • acute onset with duration of illness ranging from several weeks to months
  • while the preicteric phase can last up to 5 days, the icteric phase lasts from days to months
  • generally, Hepatitis E is a mild or inapparent infection in infants and young children

1. Preicteric Phase

1. Fever

  • may be absent in children but last up to 5 days in adolescents and adults
  • ranges from 37.8-40 C

2. Accompanying Signs/Symptoms

  • abdominal pain
  • anorexia
  • headache
  • lethargy
  • nausea/vomiting
  • hepatomegaly (tender)
  • lymphadenopathy
  • splenomegaly

2. Icteric Phase

1. Jaundice

  • transition to the icteric phase is marked by the disappearance of preicteric signs/symptoms in young children but the exacerbation of these signs/symptoms in older children and adolescents
  • accompanied by dark urine (biliuria) +/- clay-coloured stools

INVESTIGATIONS:

1. Serum

1. Alanine Aminotransferase (ALT)

  • striking rise in level after the incubation period and lasts 2-3 weeks

2. Bilirubin

  • transient elevation associated with the peak in ALT levels lasting from one day to longer than one month

3. Serology

  • a practical serologic test is not currently available as of 1992

2. Liver Biopsy

  • immune electron microscopy used to identify the virus

MANAGEMENT:

1. Supportive

  • symptomatic

2. Prognosis

  • Hepatitis E is generally a benign disease (except in pregnant women) and complete resolution of the hepatitis usually occurs - does not result in chronic hepatitis, liver disease, or a carrier state (thus a very low risk for perinatal transmission)
  • there is increased morbidity and duration of jaundice with increasing age
  • mortality from fulminant hepatitis is:
    • 1-2% in the general population
    • 10-20% in pregnant women (highest in the 3rd trimester and lowest in the 1st)

 

 

Pediatric Database - HEPATITIS E

Pediatric Organization - Pedbase [at] Gmail.com